Susan Stienen

NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure

Susan Stienen, Khibar Salah, Arno H. Moons et al. · Circulation · 2017 · 160 citations · Full text

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction

Khibar Salah, Susan Stienen, Yigal M. Pinto et al. · Heart · 2019 · 156 citations · Full text

Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels?

Susan Stienen, Khibar Salah, Luc W.M. Eurlings et al. · European Journal of Heart Failure · 2015 · 45 citations · Full text

Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)

Susan Stienen, João Pedro Ferreira, Masatake Kobayashi et al. · Biomarkers · 2020 · 40 citations · Full text

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes

Susan Stienen, Khibar Salah, A.H.M. Moons et al. · American Heart Journal · 2014 · 37 citations

Heart Failure, Prima Ii, Cardiovascular Disease +8